IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지

AIDS Vaccine Development: the Past, the Present, and the Future

  • Ahn, So-Shin (Cellular Immunology Laboratory, Division of Molecular and Life Sciences, Pohang University of Science and Technology) ;
  • Sung, Young-Chul (Cellular Immunology Laboratory, Division of Molecular and Life Sciences, Pohang University of Science and Technology)
  • Published : 2009.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men:evidence of a new acquired cellular immunodeficiency. NEngl J Med 305;1425-1431, 1981 https://doi.org/10.1056/NEJM198112103052401
  2. Barr'e-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Glin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnie L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220;868-871, 1983 https://doi.org/10.1126/science.6189183
  3. Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney SD: A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246;1293-1297, 1989 https://doi.org/10.1126/science.2555923
  4. Arthur LO, Bess JW Jr, Sowder RC 2nd, Benveniste RE, Mann DL, Chermann JC, Henderson LE: Cellular proteins bound to immunodeficiency viruses: implications for pathogenisis and vaccines. Science 258;1935-1938, 1992 https://doi.org/10.1126/science.1470916
  5. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258;1938-1941, 1992 https://doi.org/10.1126/science.1470917
  6. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM: Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267;1820-1825, 1995 https://doi.org/10.1126/science.7892606
  7. Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, Wurm FM, Hershberg RD, Cobb EK, Eichberg JW: Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345;622-625, 1990 https://doi.org/10.1038/345622a0
  8. Ready T: AIDSBAX flop leaves vaccine field unscathed. Nat Med 9;376, 2003
  9. Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fenandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz DC, Emini EA: Replicaion-incompetent adenoviral immunity. Nature 415;331-335, 2002 https://doi.org/10.1038/415331a
  10. Steinbrook R: One step forward, two steps back--will there ever be an AIDS vaccine? N Engl J Med 357;2653-2655, 2007 https://doi.org/10.1056/NEJMp0708117